AKT1 and malignant colon neoplasm: CDM was able to increase the acetylation levels of histone H3 and inhibit PI3K/AKT signaling pathway, resulting in arresting colon cancer cells at G1 phase and accelerating cell apoptosis (Liu et al., 2010).